Header Logo

Connection

Igor Koralnik to JC Virus

Back to Details
This is a "connection" page, showing publications Igor Koralnik has written about JC Virus.
Igor Koralnik
Connection Strength
18.937
JC Virus
  1. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region. J Neurovirol. 2019 08; 25(4):475-479.
    View in: PubMed
    Score: 0.616
  2. JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy. J Neurovirol. 2019 08; 25(4):520-524.
    View in: PubMed
    Score: 0.616
  3. Can Immune Checkpoint Inhibitors Keep JC Virus in Check? N Engl J Med. 2019 04 25; 380(17):1667-1668.
    View in: PubMed
    Score: 0.614
  4. ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients. PLoS One. 2018; 13(1):e0186945.
    View in: PubMed
    Score: 0.565
  5. JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression. J Virol Methods. 2015 Oct; 223:25-9.
    View in: PubMed
    Score: 0.474
  6. Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray area. Curr Opin Neurol. 2015 Jun; 28(3):288-94.
    View in: PubMed
    Score: 0.470
  7. Finger pointing to JC virus: a tale of two indexes. Ann Neurol. 2014 Dec; 76(6):789-91.
    View in: PubMed
    Score: 0.453
  8. JC virus nucleotides 376-396 are critical for VP1 capsid protein expression. J Neurovirol. 2015 Dec; 21(6):671-8.
    View in: PubMed
    Score: 0.445
  9. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.
    View in: PubMed
    Score: 0.443
  10. A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient. Ann Neurol. 2014 Jul; 76(1):140-7.
    View in: PubMed
    Score: 0.440
  11. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant. 2014 Jul; 20(7):992-9.
    View in: PubMed
    Score: 0.433
  12. Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production. PLoS One. 2013; 8(11):e80840.
    View in: PubMed
    Score: 0.422
  13. Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter. Ann Neurol. 2013 Oct; 74(4):503-5.
    View in: PubMed
    Score: 0.419
  14. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS One. 2013; 8(5):e64313.
    View in: PubMed
    Score: 0.408
  15. Comment: avoiding detrimental effects of corticosteroids on JC virus T-cell responses--primum non nocere. Neurology. 2012 Dec 04; 79(23):2263.
    View in: PubMed
    Score: 0.395
  16. JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One. 2012; 7(4):e35793.
    View in: PubMed
    Score: 0.379
  17. Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2012 Jan; 71(1):54-65.
    View in: PubMed
    Score: 0.371
  18. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol. 2012 Jan; 93(Pt 1):175-183.
    View in: PubMed
    Score: 0.364
  19. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis. 2011 Oct; 53(7):711-5.
    View in: PubMed
    Score: 0.362
  20. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol. 2011 Jul; 85(14):7256-63.
    View in: PubMed
    Score: 0.354
  21. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010 Nov; 81(11):1288-91.
    View in: PubMed
    Score: 0.337
  22. JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol. 2010 Sep; 84(18):9200-9.
    View in: PubMed
    Score: 0.335
  23. Discrepant findings in immune responses to JC virus in patients receiving natalizumab. Lancet Neurol. 2010 Jun; 9(6):565-6; author reply 566-7.
    View in: PubMed
    Score: 0.332
  24. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010 Apr; 9(4):425-37.
    View in: PubMed
    Score: 0.329
  25. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
    View in: PubMed
    Score: 0.316
  26. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol. 2009 Jun; 65(6):742-8.
    View in: PubMed
    Score: 0.310
  27. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis. 2009 Mar 15; 199(6):881-8.
    View in: PubMed
    Score: 0.306
  28. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2009 Jan; 68(1):15-25.
    View in: PubMed
    Score: 0.301
  29. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology. 2009 Jan 20; 383(2):173-7.
    View in: PubMed
    Score: 0.300
  30. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol. 2008 Oct; 14(5):455-8.
    View in: PubMed
    Score: 0.298
  31. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol. 2008 Jun; 42(2):198-202.
    View in: PubMed
    Score: 0.285
  32. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol. 2007 Apr; 81(7):3361-8.
    View in: PubMed
    Score: 0.263
  33. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol. 2006 Sep; 87(Pt 9):2533-2537.
    View in: PubMed
    Score: 0.256
  34. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J Neuroimmunol. 2006 Jul; 176(1-2):181-6.
    View in: PubMed
    Score: 0.252
  35. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol. 2006 Apr; 12(2):116-28.
    View in: PubMed
    Score: 0.249
  36. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS. 2005 Dec 02; 19(18):2069-76.
    View in: PubMed
    Score: 0.243
  37. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med. 2005 Jul 28; 353(4):414-6.
    View in: PubMed
    Score: 0.235
  38. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005 Apr; 57(4):576-80.
    View in: PubMed
    Score: 0.232
  39. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004 Sep 14; 63(5):897-900.
    View in: PubMed
    Score: 0.224
  40. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol. 2004 Sep; 78(18):10206-10.
    View in: PubMed
    Score: 0.223
  41. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004 Sep; 127(Pt 9):1970-8.
    View in: PubMed
    Score: 0.220
  42. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 2004 Jun; 17(3):365-70.
    View in: PubMed
    Score: 0.219
  43. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003 Sep 23; 61(6):775-82.
    View in: PubMed
    Score: 0.209
  44. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J Neurovirol. 2002 Dec; 8 Suppl 2:59-65.
    View in: PubMed
    Score: 0.198
  45. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol. 2002 Jan 01; 168(1):499-504.
    View in: PubMed
    Score: 0.186
  46. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol. 2001 Aug; 7(4):318-22.
    View in: PubMed
    Score: 0.180
  47. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol. 2001 Jun; 75(12):5672-6.
    View in: PubMed
    Score: 0.178
  48. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol. 2001 Apr; 75(7):3483-7.
    View in: PubMed
    Score: 0.176
  49. Brainstem progressive multifocal leukoencephalopathy. Eur J Neurol. 2021 03; 28(3):1016-1021.
    View in: PubMed
    Score: 0.172
  50. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):220-224.
    View in: PubMed
    Score: 0.159
  51. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J Neurovirol. 1999 Aug; 5(4):430-5.
    View in: PubMed
    Score: 0.157
  52. Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
    View in: PubMed
    Score: 0.153
  53. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology. 1999 Jan 15; 52(2):253-60.
    View in: PubMed
    Score: 0.151
  54. JC Virus Granule Cell Neuronopathy as AIDS-Presenting Illness. Can J Neurol Sci. 2018 07; 45(4):466-469.
    View in: PubMed
    Score: 0.146
  55. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient. Transplantation. 2017 06; 101(6):1461-1467.
    View in: PubMed
    Score: 0.135
  56. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J Neurovirol. 2016 08; 22(4):464-71.
    View in: PubMed
    Score: 0.122
  57. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 Aug; 74(8):791-803.
    View in: PubMed
    Score: 0.119
  58. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
    View in: PubMed
    Score: 0.110
  59. JC polyomavirus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol. 2014 Apr; 71(4):487-9.
    View in: PubMed
    Score: 0.108
  60. Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J. 2014 Apr; 33(4):e99-105.
    View in: PubMed
    Score: 0.108
  61. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014 Jun; 58(12):1771-7.
    View in: PubMed
    Score: 0.108
  62. A game of viral hide and seek: miliary PML masquerading as EBV encephalitis in an HIV+ patient. Clin Neurol Neurosurg. 2013 Sep; 115(9):1861-3.
    View in: PubMed
    Score: 0.101
  63. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol. 2013 Jan 24; 8:189-215.
    View in: PubMed
    Score: 0.098
  64. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):244-8.
    View in: PubMed
    Score: 0.096
  65. Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy. J Neurovirol. 2010 Feb; 16(1):41-7.
    View in: PubMed
    Score: 0.081
  66. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009 Nov 10; 73(19):1551-8.
    View in: PubMed
    Score: 0.080
  67. Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML). Int Immunol. 2007 Sep; 19(9):1083-93.
    View in: PubMed
    Score: 0.068
  68. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol. 2006 Aug; 60(2):162-73.
    View in: PubMed
    Score: 0.064
  69. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J Neurovirol. 2005 Feb; 11(1):46-50.
    View in: PubMed
    Score: 0.057
  70. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab. J Neurovirol. 2005; 11 Suppl 3:52-7.
    View in: PubMed
    Score: 0.057
  71. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol. 2003 Nov; 77(22):11918-26.
    View in: PubMed
    Score: 0.053
  72. Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells. Int J Mol Sci. 2021 Sep 10; 22(18).
    View in: PubMed
    Score: 0.045
  73. JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol. 2017 02; 23(1):141-146.
    View in: PubMed
    Score: 0.032
  74. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neurovirol. 2016 08; 22(4):541-5.
    View in: PubMed
    Score: 0.031
  75. Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS. J Neurovirol. 2011 Oct; 17(5):500-3.
    View in: PubMed
    Score: 0.022
  76. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009 Oct; 9(10):625-36.
    View in: PubMed
    Score: 0.020
  77. Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia. J Clin Oncol. 2008 Aug 01; 26(22):3804-7.
    View in: PubMed
    Score: 0.018
  78. Meningoencephalitis and demyelination are pathologic manifestations of primary polyomavirus infection in immunosuppressed rhesus monkeys. J Neuropathol Exp Neurol. 2004 Jul; 63(7):750-8.
    View in: PubMed
    Score: 0.014
  79. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro Oncol. 2002 07; 4(3):165-70.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.